Background: This is a multicenter, randomized, double-blind, active-controlled study to evaluate the effects of LCZ696 compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction Sponsor: Novartis Trial Registration No: NCT02884206 (clinicaltrials.gov) Link Trial Status: Recruitment stopped Enrolling Centers: Worldwide: multicentric Core Study Team:
© Christian Mueller, 2012 - 2022 │ DisclaimerImprintWebmaster │ Last Update: August 2022
Ina-Maria Ferel, Ph.D. Svetlana Stanojkovic